Skip to main content
Clinical Trials/NL-OMON49834
NL-OMON49834RecruitingNot Applicable

SMA Motor Map - an extensive neurophysiologic protocol to assess (dys)function of the peripheral motor circuits in SMA - SMA Motor Map

niversitair Medisch Centrum Utrecht0 sites177 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
177

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
12 to 99 (—)

Inclusion Criteria

  • SMA type 1, 2, 3 and 4, confirmed with a homozygous or heterozygous deletion
  • *12 years and older
  • Treatment-naïve concerning SMN- modulators or NMJ-modulators (including
  • pyri-dostigmine and oral salbutamol)
  • o In case of the use of pyridostigmine by indication of SMA, patients are asked
  • to stop treatment 1 day prior to the examination
  • SMA type 1, 2, 3 and 4, confirmed with a homozygous or heterozygous deletion
  • *12 years and older
  • Treatment with SMN- modulator

Exclusion Criteria

  • Strong apprehension against the performance of EMG of any kind

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials